A practical reference on AOD-9604: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-12-29. Anything still debated is marked as such rather than presented as settled.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The mother of an 18-year-old who killed himself in 2021 sued anti-vaccine campaigner Gemma O'Doherty for misrepresenting and sensationalising his death in the freesheet, The Irish Light, last year to support conspiracy theory about the COVID-19 vaccine. 30 May – Ireland's 2022 census figures from the CSO show an older population, increased diversity, decreased religiosity, and a population surpassing five million for the first time since the great famine.
Polyethersulfone (PES) is also referred to as polyetherketone and polysulfone. It is synthesized by nucleophilic aromatic substitution between aromatic dihalides and bisphenolate salts. Polyethersulfones are partially crystalline and highly resistant to a wide range of aqueous and organic environments. They are rated for continuous service at temperatures of 240–280 °C. The polyketones are finding applications in areas like automotive, aerospace, electrical-electronic cable insulation.
21 September – Daniel Dubois defeats Anthony Joshua at Wembley Stadium to become the International Boxing Federation's heavyweight champion. 22 September The Crown Prosecution Service confirms it considered prosecuting Mohamed Al Fayed on two occasions, but concluded there was no realistic prospect of securing a conviction. Secretary of State for Defence John Healey announces that people with asthma and acne will no longer be excluded from joining the British Armed Forces. 23 September Heavy rain brings flash flooding and travel disruption to parts of England and Wales. Harrods reveals that it is investigating whether any current members of staff have made allegations against Mohamed Al Fayed. It is reported that in a letter written in 2019, Ministry of Defence officials concluded privately that allegations to be aired in a BBC Panorama on alleged SAS war crimes were “broadly accurate”. The Royal College of Nursing announces that nurses in England have rejected the offer of a 5.5% pay increase from the government. 24 September Starmer gives his keynote conference speech, setting out plans for "national renewal" but telling delegates there are no "easy answers". Home Secretary Yvette Cooper announces plans to halve instances of knife crime over the next decade. Legislation making it illegal to own, make, transport or sell "status knives", such as zombie knives and machetes, in England and Wales, comes into force.
In 2010, the Ghent nosology was revised, and new diagnostic criteria superseded the previous agreement made in 1996. The seven new criteria can lead to a diagnosis: In the absence of a family history of MFS:
Atkins, P.W., Overton, T., Rourke, J., Weller, M. and Armstrong, F. Shriver and Atkins Inorganic Chemistry (4th ed.) 2006 (Oxford University Press) ISBN 0-19-926463-5 Chang, Raymond. Chemistry 6th ed. Boston, Massachusetts: James M. Smith, 1998. ISBN 0-07-115221-0 Clayden, Jonathan; Greeves, Nick; Warren, Stuart; Wothers, Peter (2001). Organic Chemistry (1st ed.). Oxford University Press. ISBN 978-0-19-850346-0. Tucker, William (2024). Chemistry: Energy, Matter, and Change. CRC Press. ISBN 9781003479338. Advanced undergraduate-level or graduate textbooks
Sources: en.wikipedia.org
=== High-throughput === Due to the highly time-consuming and work-intensive standard procedure, the method of in-gel digestion was limited to a relatively small number of protein spots to be processed at a time. Therefore, it has been found to be the ideal object for automation ambitions to overcome these limitations for industrial and service laboratories. Today, in laboratories where in-gel digestion is performed in high-throughput quantities, the procedure is usually automated. The degree of automation varies from simple pipetting robots to highly sophisticated all-in-one solutions, offering an automated workflow from gel to mass spectrometry. The systems usually consist of a spot picker, a digestion robot, and a spotter. The advantages of the automation other than the larger number of spots to be processed at a time are the reduced manual work and the improved standardisation. Due to the many handling steps of the method, the results of the manual process could vary depending on the dexterity of the user and the risk of contamination is high. Therefore, the quality of the results is described to be one main advantage of the automated process. Drawbacks of automated solutions are the costs for robots, maintenance and consumables as well as the complicated setup of the process. Since the automated picking needs digitised information of the spot location, the analysis of the gel image for relevant spots has to be done by software requiring standardised imaging methods and special scanners.
A schematic of the optical systems is shown in Figure 1. The variable UV-Vis absorbance detector's optical bench is showing how the flow cell is positioned after the optical system, including the monochromator, which typically has a physical slit and a moving grating, so it is illuminated by a selected wavelength, reaching a photo-diode. The bench of the diode array detector, however, is configured so that the flow cell is positioned before the optical parts, so that the beam containing the entire spectrum is passing through it. The optical parts consist also with a monochromator and a slit, but with a fixed grating, which disperses the light onto a diode array imaging element.
== Advocacy == Prior to gaining mainstream attention, Saladino was vegan. As an advocate of the strict meat only carnivore diet, Saladino argued that the diet could "cure everything ranging from depression to autoimmune conditions", and claimed that the diet cured his anxiety and eczema. He transitioned away from a strict carnivore diet by 2020 by adding carbohydrates to his diet, including fruit and honey. While on the carnivore diet, Saladino reported experiencing sleep disturbances, heart palpitations, muscle cramps, and a drop in testosterone levels. He said: "I started to think, maybe long-term ketosis is not great for me" and "probably not a great thing for most humans". Saladino's content often features him vlogging and presenting lifestyle advice and his personal routine, in scenarios varying from supermarket trips to surfing on his Costa Rican estate. He promotes the consumption of animal organs, claiming they help immunity, gut health, weight loss and bone strength. Saladino has urged his followers to use a bidet instead of toilet paper, claiming that toilet paper is "filled with hormone disrupting compounds" and that he avoids contact with them to "protect" his "hormonal health". According to Vice.com, during the Coronavirus pandemic, he was increasingly dismissive of the efficacy of vaccines contrary to mainstream scientific opinion, although saying they "may help avoid some severe COVID-19 complications." However, he asserted that "metabolic health" and "natural immunity" are more effective, also against medical consensus.
In November 2023, the two debated, with Fox News's Sean Hannity as moderator. In July 2024, Newsom launched a podcast, Politickin', co-hosted by Marshawn Lynch and Doug Hendrickson. After Biden's sudden withdrawal from the presidential race that month, Newsom said he would not seek the Democratic nomination, and endorsed Vice President Kamala Harris for president. After Donald Trump won the 2024 election, Newsom called for California lawmakers to convene later in 2024 to safeguard California's policies from the second Trump administration. In December 2024, Newsom criticized Biden for pardoning his son Hunter, saying, "I'm disappointed and can't support the decision." Since the 2024 U.S. presidential election, Newsom has repeatedly declined to identify himself with either the progressive or moderate faction of the Democratic Party, calling such labels "reductive" and calling himself a "hard-headed pragmatist". He said he wants the Democratic Party to be an "inclusive" big tent, spanning the ideological spectrum "from Manchin to Mamdani". In August 2025, Newsom began communicating on social media platforms in a style intended to mock Trump's style of online communication. In June 2026, Newsom said the United States Department of Justice was prosecuting him and his wife at Trump's direction.
Mitogen-activated protein kinase 1 (MAPK1) is also known as extracellular signal-regulated kinase 2 (ERK2). Two similar protein kinases with 85% sequence identity were originally called ERK1 and ERK2. They were found during a search for protein kinases that are rapidly phosphorylated after activation of cell surface tyrosine kinases such as the epidermal growth factor receptor. Phosphorylation of ERKs leads to the activation of their kinase activity. The molecular events linking cell surface receptors to activation of ERKs are complex. It was found that Ras GTP-binding proteins are involved in the activation of ERKs. Another protein kinase, Raf-1, was shown to phosphorylate a "MAP kinase-kinase", thus qualifying as a "MAP kinase kinase kinase". The MAP kinase-kinase, which activates ERK, was named "MAPK/ERK kinase" (MEK). Receptor-linked tyrosine kinases, Ras, Raf, MEK, and MAPK could be fitted into a signaling cascade linking an extracellular signal to MAPK activation. See: MAPK/ERK pathway. Transgenic gene knockout mice lacking MAPK1 have major defects in early development. Conditional deletion of Mapk1 in B cells showed a role for MAPK1 in T-cell-dependent antibody production. A dominant gain-of-function mutant of Mapk1 in transgenic mice showed a role for MAPK1 in T-cell development. Conditional inactivation of Mapk1 in neural progenitor cells of the developing cortex lead to a reduction of cortical thickness and reduced proliferation in neural progenitor cells.
Sources: en.wikipedia.org
=== Overdose === Human tolerance to xylazine varies widely, with toxicity and fatality occurring between doses of 40–2,400 mg (0.62–37.04 gr). Non-fatal blood or plasma concentration ranges from 0.03 to 4.6 mg/L. In fatalities, the blood concentration of xylazine ranges from trace to 16 mg/L. It is reported that there is no defined safe or fatal concentration of xylazine because of the significant overlap between the non-fatal and postmortem blood concentrations of xylazine. Hemodialysis has been suggested as a form of treatment, but is usually unfavorable due to the large volume of distribution of xylazine. There are no standardized screenings to determine if an overdose has occurred. Detection of xylazine in humans involves various screening methods, such as urine screenings, thin layer chromatography (TLC), gas chromatography–mass spectrometry (GC-MS) and liquid chromatography–mass spectrometry (LC-MS). As of November 2022, detecting xylazine in a drug sample requires spectrophotometry. As of 1998, the α2-adrenergic receptor antagonist atipamezole was used to reverse the effects of xylazine or the related drug dexmedetomidine in veterinary medicine, but this is not an approved medical treatment for humans, despite Phase I clinical trials in 2005. As of 2001, the effects of xylazine in animals were also reversed by the analeptics 4-aminopyridine, doxapram, and caffeine, which are physiological antagonists to central nervous system depressants. The ways to accurately identify chronic xylazine use are unknown, and the effective treatments, if any, are not standardized.
Roseanne Park. Musician/Performer. For services to the United Kingdom COP 26 Presidency and advocacy for the 2021 United Nations Climate Change Conference of the Parties. Gina Cecile Petrie. Director, Department of Environment, Cayman Islands. For services to the Environment and to the community in the Cayman Islands. Richard Anthony Power. Orthopaedic Surgeon, University Hospitals of Leicester NHS Trust; Chair, Health Action Leicester in Ethiopia. For services to Health in Gondar, Northern Ethiopia. Natalie Ray Pray. Former President, the St George's Society, New York, United States of America. For services to UK/US Cultural Relations and to Philanthropy. Phillip Christopher Robinson. Team Leader, Foreign, Commonwealth and Development Office. For services to National Security. James Andrew Rogers. Head of Coordination, Windsor Framework Taskforce, Foreign, Commonwealth and Development Office. For services to British Foreign Policy. Lynette Silver. Historian and Author. For services to British Families of World War II personnel. Claire Sonia van Straubenzee. Founder and Trustee, The Henry van Straubenzee Memorial Fund. For services to Children's Education in Uganda. Edward Robert Syfret. Angola Programme Manager, the HALO Trust. For services to Humanitarian Demining in Angola. Margery Anne Taylor. District Treasurer and District Training Officer, Royal British Legion, Spain South. For services to Veterans in Spain. Jacqueline Barbara Teasdale (Tig James). Co-President, British in Portugal. For services to the British Community in Portugal. John Robert Thurlow.
=== Conflicts of interest === In 2012, Labcorp was criticized for its practice of paying the salaries of genetic counselors in hospitals and doctors' offices, which is perceived to be a possible conflict of interest.
== Medical uses == Beta blockers are utilized in the treatment of various conditions related to the heart and vascular system, as well as several other medical conditions. Common heart-related conditions for which beta blockers are well-established include angina pectoris, acute coronary syndromes, hypertension, and arrhythmias such as atrial fibrillation and heart failure. They are also used in the management of other heart diseases, such as hypertrophic obstructive cardiomyopathy, mitral valve stenosis or prolapse, and dissecting aneurysm. Additionally, beta blockers find applications in vascular surgery, the treatment of anxiety states, cases of thyrotoxicosis, glaucoma, migraines, and esophageal varices.
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.